FDA Approves Adcetris To Treat Two Types Of Lymphoma
Links shared publicly online about this topic.
- 59total visits
FDA Approves Adcetris To Treat Two Types Of Lymphoma
View full resource at medicalnewstoday.com
Tags: Cancer, Leukemia, Lymphoma, Hodgkin Lymphoma, Diet and Nutrition, Drug, FDA
Most Recently Shared on August 22, 2011 at 5:29 pm By:
FDA Approves Adcetris To Treat Two Types Of Lymphoma http://t.co/bf6V8hN via @mnt_leukemia #health #medicine
Also Shared By:
FDA Approves New Drug for Lymphoma
webmd.com — “The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin's lymphoma and a rare type of the disease known as systemic anaplastic large cell lymphoma (ALCL).” View full resource at webmd.com
Most Recently Shared on August 22, 2011 at 6:00 pm By:
RT @webmd: FDA Approves New Drug for Lymphoma http://t.co/evvCAO6
FDA Approves New Drug for Lymphoma - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin's lymphoma and a rare type of the disease known as systemic anaplastic large cell lymphoma (ALCL). (Source: WebMD Health)” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2011 at 3:00 pm By:
FDA Approves New Drug for Lymphoma: The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin... http://t.co/211DOTP
FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL
news-medical.net — “Seattle Genetics, Inc. today announced that the U.S. Food and Drug Administration has granted accelerated approval of ADCETRISTM for two indications: (1) the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, and (2) the treatment of patients with systemic anaplastic large cell lymphoma after failure of at least one prior multi-agent chemothe” View full resource at news-medical.net
Most Recently Shared on August 20, 2011 at 7:44 am By:
News-Medical.Net Health News and Oncology
Oncology News: FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL: Seattle Genetics, In... http://t.co/lQmBAUv
FDA Approves New Drug for Lymphoma - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin's lymphoma and a rare type of the disease known as systemic anaplastic large cell lymphoma (ALCL). (Source: WebMD Health)” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2011 at 1:00 am By:
FDA Approves New Drug for Lymphoma: The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin... http://t.co/JkP4DIP
FDA Approves Adcetris to Treat Two Types of Lymphoma
drugs.com — “Adcetris (brentuximab vedotin) is used to treat Hodgkin lymphoma and systemic anaplastic large cell lymphoma . Includes Adcetris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 19, 2011 at 9:09 pm By:
Drugs and Devices OW OW Health
FDA Approves Adcetris to Treat Two Types of Lymphoma: August 19, 2011 - The U.S. Food and Drug Administrat... http://t.co/QLmCG1d #drug
FDA Approves Adcetris to Treat Two Types of Lymphoma
drugs.com — “Adcetris (brentuximab vedotin) is used to treat Hodgkin lymphoma and systemic anaplastic large cell lymphoma . Includes Adcetris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 19, 2011 at 8:34 pm By:
FDA Approves Adcetris to Treat Two Types of Lymphoma - http://t.co/4maXtfp
Medical News: FDA Panel Gives Nod to Two Cancer Drugs - in Hematology/Oncology, Lymphoma from MedPage Today
medpagetoday.com — “Washington -- an fda advisory panel on wednesday recommended the agency approve two investigational drugs to treat two uncommon types of non-hodgkin's lymphoma.” View full resource at medpagetoday.com
Most Recently Shared on September 3, 2009 at 6:58 pm By:
More on the two #Lymphoma drugs that got the thumbs up yesterday from the FDA panels, Romidepsin & Folotyn. http://bit.ly/3PfMKc
Advertisement
MNT Leukemia
@mnt_leukemia
FDA Approves Adcetris To Treat Two Types Of Lymphoma http://mnt.to/3Z5T #lymphoma #leukemia
1 year ago...